Stonepine Capital Management, LLC

Est. AUM

$249.72B

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

View filings ↗

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	SPDR SERIES TRUSTPUT	STATE STREET SPD	$51.09B	400000	20.46%	SOLE
2	SPDR SERIES TRUSTCALL	STATE STREET SPD	$51.09B	400000	20.46%	SOLE
3	VERASTEM INC	COM NEW	$17.50B	3302300	7.01%	SOLE
4	TENAX THERAPEUTICS INC	COM NEW	$15.59B	975200	6.24%	SOLE
5	ADMA BIOLOGICS INCCALL	COM	$10.36B	1150000	4.15%	SOLE
6	EVOLUS INC	COM	$7.23B	1759091	2.90%	SOLE
7	ADMA BIOLOGICS INC	COM	$6.67B	740000	2.67%	SOLE
8	CAMP4 THERAPEUTICS CORP	COM	$6.13B	1389622	2.45%	SOLE
9	NEKTAR THERAPEUTICS	COM NEW	$6.12B	85000	2.45%	SOLE
10	TERNS PHARMACEUTICALS INCCALL	COM	$5.27B	100000	2.11%	SOLE
11	ZEVRA THERAPEUTICS INC	COM NEW	$4.47B	480000	1.79%	SOLE
12	CORBUS PHARMACEUTICALS HLDGS	COM NEW	$3.60B	383462	1.44%	SOLE
13	ABEONA THERAPEUTICS INC	COM NEW	$3.34B	746587	1.34%	SOLE
14	ESTABLISHMENT LABS HLDGS INCCALL	COM	$2.84B	50000	1.14%	SOLE
15	KAZIA THERAPEUTICS LTD	SPONSORED ADS	$2.57B	345179	1.03%	SOLE
16	AN2 THERAPEUTICS INC	COM	$2.44B	713845	0.98%	SOLE
17	ALEXANDRIA REAL ESTATE EQ INCALL	COM	$2.32B	50000	0.93%	SOLE
18	ACADIA PHARMACEUTICALS INCCALL	COM	$2.23B	100000	0.89%	SOLE
19	SOL-GEL TECHNOLOGIES LTD	SHS NEW	$2.20B	27778	0.88%	SOLE
20	XOMA ROYALTY CORPORATION	COM NEW	$2.18B	69500	0.87%	SOLE
21	AYTU BIOPHARMA INC	COM	$2.16B	792289	0.87%	SOLE
22	CURIS INC	COM	$2.04B	3726406	0.82%	SOLE
23	EVOLUS INCCALL	COM	$1.73B	420000	0.69%	SOLE
24	XERIS BIOPHARMA HOLDINGS INCCALL	COM	$1.62B	280000	0.65%	SOLE
25	TELA BIO INC	COM	$1.62B	2617252	0.65%	SOLE
26	INHIBIKASE THERAPEUTICS INC	COM NEW	$1.61B	957202	0.64%	SOLE
27	CRESCENT BIOPHARMA INC.	COM	$1.56B	85000	0.63%	SOLE
28	ADICET BIO INC	COM NEW	$1.51B	221955	0.61%	SOLE
29	X4 PHARMACEUTICALS INC	COM NEW	$1.38B	335309	0.55%	SOLE
30	OKYO PHARMA LTD	SHS NEW	$1.37B	850000	0.55%	SOLE
31	SI BONE INCCALL	COM	$1.26B	100000	0.51%	SOLE
32	MANNKIND CORPCALL	COM NEW	$1.23B	500000	0.49%	SOLE
33	HERON THERAPEUTICS INC	COM	$1.12B	1402191	0.45%	SOLE
34	PULMONX CORP	COM	$991.1M	768288	0.40%	SOLE
35	IN8BIO INC	COM NEW	$981.9M	663412	0.39%	SOLE
36	NEUMORA THERAPEUTICS INC.CALL	COM	$975.0M	500000	0.39%	SOLE
37	SURROZEN INC	COM NEW	$961.4M	33005	0.39%	SOLE
38	CYTOMX THERAPEUTICS INC.	COM	$940.0M	200000	0.38%	SOLE
39	CYTOMX THERAPEUTICS INC.CALL	COM	$940.0M	200000	0.38%	SOLE
40	DELCATH SYS INCCALL	COM NEW	$928.0M	100000	0.37%	SOLE
41	ARDELYX INCCALL	COM	$898.5M	150000	0.36%	SOLE
42	PMV PHARMACEUTICALS INC	COM	$878.0M	708102	0.35%	SOLE
43	BIOAGE LABS INC	COM	$874.5M	50000	0.35%	SOLE
44	CONNECT BIOPHARMA HLDGS LTD	SHS	$812.2M	310000	0.33%	SOLE
45	HERON THERAPEUTICS INCCALL	COM	$800.1M	1000000	0.32%	SOLE
46	RADIOPHARM THERANOSTICS LTD	SPONSORED ADS	$739.0M	51000000	0.30%	SOLE
47	MAXCYTE INC	COM	$705.8M	1004673	0.28%	SOLE
48	CODEXIS INC	COM	$681.3M	417994	0.27%	SOLE
49	BOUNDLESS BIO INC	COM	$657.5M	597682	0.26%	SOLE
50	CYBIN INC	COM NEW	$643.5M	134060	0.26%	SOLE

1–50 of 83

1 / 2

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.